Prot #NU 16C02: A Phase 2, Single arm, Multi-center, Open Label Trial Combining Optune with Concurrent Bevacizumab in the Setting of Recurrent or Progressive Meningioma

Project: Research project

Project Details

StatusActive
Effective start/end date6/3/166/1/22

Funding

  • Novocure Ltd (Prot #NU 16C02)
  • Novocure Inc. (Prot #NU 16C02)